KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Accured Expenses (2016 - 2026)

Staar Surgical (STAA) has disclosed Change in Accured Expenses for 17 consecutive years, with $629000.0 as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 82.83% year-over-year to $629000.0, compared with a TTM value of -$4.6 million through Jan 2026, down 17626.92%, and an annual FY2026 reading of -$4.6 million, down 17626.92% over the prior year.
  • Change in Accured Expenses was $629000.0 for Q1 2026 at Staar Surgical, down from $2.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $12.2 million in Q3 2022 and bottomed at -$12.7 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is $166375.0, with a median of $500.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses skyrocketed 60715.38% in 2023, then tumbled 38730.77% in 2024.
  • Year by year, Change in Accured Expenses stood at $13000.0 in 2022, then surged by 60715.38% to $7.9 million in 2023, then tumbled by 53.67% to $3.7 million in 2024, then tumbled by 38.74% to $2.2 million in 2025, then tumbled by 71.97% to $629000.0 in 2026.
  • Business Quant data shows Change in Accured Expenses for STAA at $629000.0 in Q1 2026, $2.2 million in Q3 2025, and -$12.7 million in Q2 2025.